Edit

https://www.av.co/
Last activity: 06.06.2024
Active
Mentions
33

Investors 1

Mentions in press and media 33

DateTitleDescription
06.06.2024Eko Health Secures $41 Million to Revolutionize Heart and Lung DetectionEko Health, a trailblazer in the realm of AI-powered early detection of heart and lung diseases, has successfully closed a Series D financing round, raising an impressive $41 million. This significant funding round, spearheaded by ARTIS Ven...
05.06.2024Eko Health Raises $41M to Scale AI-driven Heart, Lung DetectionWhat You Should Know: – Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million. – This funding, led by ARTIS Ventures, Highland Capital Partners, N...
10.05.2024Revolutionizing Radiology Reporting with Rad AIIn the fast-paced world of healthcare, where time is of the essence and accuracy is paramount, the role of radiologists in diagnosing and treating patients is crucial. Rad AI, a trailblazer in the realm of generative AI for healthcare, has ...
07.05.2024Rad AI Scores $50M to Empower Radiologists with Generative AIRad AI What You Should Know: – Rad AI, a leader in generative AI for healthcare, announced today it has raised $50M in Series B financing, bridging its total capital raised to over $80M. – The round was led by Khosla Ventures, with particip...
06.05.2024OverT Bio Secures $16M to Optimize Cell Therapy for Solid TumorsWhat You Should Know: – OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing VC, the round saw participa...
27.02.2024Freenome scores $254M to advance its cancer-detection blood testsThe San Francisco company readies to reveal its first clinical study results in the near term When it comes to cancer, spotting it early can make a big difference on treatment options and survival. Commonly a progressive disease, certain un...
20.02.2024Freenome's $254M Boost for Early Cancer DetectionFreenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance their blood-based cancer detection tests. The investment, led by Roche and backed by a slew of other big names, will propel Freenome's mission ...
15.02.2024Freenome Raises $254M to Accelerate Early Cancer Detection PlatformWhat You Should Know: – Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was led by Roche with parti...
19.12.2023UNP Scores $32M for AI-Powered Macrocycle TherapeuticsWhat You Should Know: – Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding. – Led by Merck Global Health In...
14.12.2023ARTIS Ventures Closes $200M TechBio Fund to Support Next Era of Health & Medicine InnovationWhat You Should Know: – ARTIS Ventures, a pioneer in this “TechBio” revolution, announces the closing of its second fund, TechBio II, with $200M focused on healthcare and biology innovation. – The fund aims to support early-stage companies ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In